MarketCap
Senseonics Holdings SENS
€ 8.95
4.36%
Facebook
X
Telegram
Senseonics Holdings PEG | SENS
PEG Jährlich Senseonics Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.0158 | -0.00109 | 0.459 | -5.71 | 0.175 | 0.0614 | 0.82 | 0.232 | 1.26 | 0.114 | 0.000226 | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.26 | -5.71 | -0.237 |
PEG anderer Aktien in der Diagnostik & Forschung
| Name | PEG | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Koninklijke Philips N.V.
PHG
|
0.115 | $ 30.39 | -1.32 % | $ 28.8 B |  Niderland |
 |
RadNet
RDNT
|
-52.5 | $ 77.91 | -0.6 % | $ 5.86 B |  USA |
 |
Neuronetics
STIM
|
0.16 | $ 2.01 | -7.8 % | $ 133 M | USA |
 |
T2 Biosystems
TTOO
|
-0.000065 | - | -39.35 % | $ 313 K | USA |
 |
Thermo Fisher Scientific
TMO
|
9.74 | $ 719.09 | -0.35 % | $ 271 B | USA |
 |
Biocept
BIOC
|
-0.000272 | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
-3.43 | $ 155.43 | -2.12 % | $ 19.5 B | USA |
 |
Akumin
AKU
|
0.0277 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Brainsway Ltd.
BWAY
|
-3.2 | $ 10.63 | -8.68 % | $ 361 M |  Israel |
 |
VolitionRx Limited
VNRX
|
-0.405 | $ 0.19 | -6.2 % | $ 23.9 M |  Singapore |
 |
Natera
NTRA
|
-17.7 | $ 311.81 | -1.92 % | $ 42.6 B | USA |
 |
IQVIA Holdings
IQV
|
1.57 | $ 275.46 | -1.21 % | $ 47.4 B | USA |
 |
Agilent Technologies
A
|
1.95 | $ 178.84 | -0.74 % | $ 50.8 B | USA |
 |
Quotient Limited
QTNT
|
-0.0164 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Chembio Diagnostics
CEMI
|
-0.0348 | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
-0.0302 | - | -11.32 % | $ 2.94 M | USA |
 |
Surmodics
SRDX
|
0.627 | - | - | $ 608 M | USA |
 |
Invitae Corporation
NVTA
|
0.225 | - | - | $ 21.2 M | USA |
 |
Syneos Health
SYNH
|
2.05 | - | - | $ 4.46 B | USA |
 |
Motus GI Holdings
MOTS
|
-0.000026 | - | -34.28 % | $ 263 K | Israel |
 |
Heska Corporation
HSKA
|
3.41 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-0.000399 | - | -20.0 % | $ 1.06 M | USA |
 |
Renalytix AI plc
RNLX
|
-0.0535 | - | 5.66 % | $ 22.7 M |  Britain |
 |
Psychemedics Corporation
PMD
|
0.0317 | - | -1.84 % | $ 15.3 M | USA |
 |
Meridian Bioscience
VIVO
|
2.18 | - | - | $ 1.49 B | USA |
 |
DexCom
DXCM
|
1.12 | $ 79.92 | -1.42 % | $ 31.2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
6.06 | $ 258.38 | -0.5 % | $ 28.7 B | USA |
 |
Castle Biosciences
CSTL
|
-0.628 | $ 34.41 | 0.07 % | $ 997 M | USA |
 |
IDEXX Laboratories
IDXX
|
3.06 | $ 696.77 | -1.4 % | $ 56 B | USA |
 |
Illumina
ILMN
|
2.16 | $ 214.84 | -2.69 % | $ 33.3 B | USA |
 |
Anixa Biosciences
ANIX
|
-0 | $ 3.05 | -3.48 % | $ 99 K | USA |
|
Biodesix
BDSX
|
-0.0233 | $ 10.04 | -2.95 % | $ 75.8 M | USA |
 |
BioNano Genomics
BNGO
|
-0.000157 | $ 1.25 | 7.66 % | $ 6.81 M | USA |
 |
Fulgent Genetics
FLGT
|
0.21 | $ 25.83 | -1.22 % | $ 795 M | USA |
 |
CareDx, Inc
CDNA
|
-1.49 | $ 80.78 | -4.31 % | $ 4.3 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
2.29 | - | - | $ 562 M | Britain |
 |
Biomerica
BMRA
|
-0.0176 | $ 1.48 | -4.52 % | $ 4.31 M | USA |
 |
Interpace Biosciences
IDXG
|
-0.00238 | $ 7.0 | -13.43 % | $ 31 M | USA |
 |
Fluidigm Corporation
FLDM
|
-0.383 | - | 1.08 % | $ 308 M | USA |
 |
ICON Public Limited Company
ICLR
|
4.55 | $ 204.62 | -1.43 % | $ 16 B |  Irlanda |
 |
Co-Diagnostics
CODX
|
-0.000246 | $ 0.29 | -9.5 % | $ 386 K | USA |
 |
Burning Rock Biotech Limited
BNR
|
0.283 | $ 13.19 | 6.46 % | $ 135 M |  China |
 |
PRA Health Sciences, Inc.
PRAH
|
-2.1 | - | - | $ 10.7 B | USA |
 |
DarioHealth Corp.
DRIO
|
-0.00446 | $ 2.37 | 15.05 % | $ 9.44 M | Israel |
 |
Myriad Genetics
MYGN
|
-0.00978 | $ 5.66 | -1.39 % | $ 524 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-0.000061 | $ 4.78 | -1.24 % | $ 3.76 M | USA |
 |
QIAGEN N.V.
QGEN
|
3.43 | $ 50.52 | -0.07 % | $ 11 B | Niderland |
 |
NeoGenomics
NEO
|
0.0904 | $ 16.97 | -3.58 % | $ 2.17 B | USA |